SPONSOR
Baptist Health South Florida
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2
Baptist Health South Florida is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Brain Metastases, Brain Metastases, Adult, Brain Cancer, Meningioma.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Baptist Health South Florida
How many clinical trials has Baptist Health South Florida sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Baptist Health South Florida, of which 3 are actively recruiting participants. These trials cover conditions including Brain Metastases, Brain Metastases, Adult, Brain Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Baptist Health South Florida research focus on?
Baptist Health South Florida clinical trials span Brain Metastases, Brain Metastases, Adult, Brain Cancer, Meningioma. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Baptist Health South Florida clinical trial?
To participate in a Baptist Health South Florida trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Baptist Health South Florida trials with current recruitment status updated daily.
Clinical Trials by Baptist Health South Florida
NCT06048094 Phase 1
Recruiting
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
Brain Metastases
NCT05425004 Phase 2
Recruiting
Cabozantinib for Patients With Recurrent or Progressive Meningioma
Meningioma
NCT05554302 Phase 2
Recruiting
Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
Brain Metastases
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology